Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-04 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.240 | (EXPECTED) 2021-03-02 | |||||
REV | 14.400M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
STIM | Neuronetics | 15.70 | -2.10 | -11.8% | 385.3M |
You can purchase shares of Neuronetics (NASDAQ: STIM) through any online brokerage.
Other companies in Neuronetics’s space includes: Oxford Immunotec Global (NASDAQ:OXFD), PAVmed (NASDAQ:PAVM) and Soliton (NASDAQ:SOLY).
The latest price target for Neuronetics (NASDAQ: STIM) was reported by William Blair on 2021-01-22. The analyst firm set a price target for 0.00 expecting STIM to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Neuronetics (NASDAQ: STIM) is $15.7 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Neuronetics.
There is no upcoming split for Neuronetics.